Navigation Links
Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
Date:1/30/2013

" "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
10. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
11. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 According ... Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, ... Manifold, & Rotary) & Geography - Global Trends ... and segments the lyophilization market on the basis ... and projections of the market size of each ...
(Date:9/19/2014)... 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and approved all parts required to build nine ... to manufacture the new PCT-based instrument system.  The ... for shipment by mid-October and that additional Barozyme ... rate of about one per week thereafter.  ...
(Date:9/19/2014)... N.Y. , Sept. 19, 2014  BioSpecifics Technologies Corp. ... in class collagenase-based products marketed as XIAFLEX ® in ... today that BioSpecifics, President, Tom Wegman , will present ... NewsMakers in the Biotech Industry Conference. The ... 3:00 p.m. EDT at the Millennium Broadway Hotel in ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2
(Date:9/19/2014)... 2014 Consistent premium price increases ... Vision Insurance industry in recent years; however, costs ... industry margins. From 2009 to 2014, industry revenue ... coverage for routine eye exams and other procedures, ... lens and refractive surgery. According to IBISWorld Industry ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 Are ... tissue because of problems with seasonal allergies or sinus ... a much better alternative. , She conceived of ... with having a runny nose in public. Since it ... it promotes more sanitary conditions, particularly when cooking or ...
(Date:9/19/2014)... 19, 2014 BearCom, a nationwide ... detailed the key role played by instant, one-to-one ... the healthcare industry. , “In healthcare, speed ... – and in emergency situations, can save precious ... and death,” said Hugh Johnston, Product & Purchasing ...
(Date:9/19/2014)... On September 16, Camino Public Relations was ... Top Places to Work in PR Awards Luncheon at ... honorable mentions in two categories for “Multicultural Campaign” and ... Latina voices in the media. , "We're honored to ... of its efforts to improve the national conversation about ...
(Date:9/19/2014)... AZ (PRWEB) September 19, 2014 Hastings and ... 30 years in the industry, announces a record number of ... handles a wide variety of serious injury cases as well ... along with dog bite related accident cases and others. Having ... and Hastings has stood the test of time when it ...
Breaking Medicine News(10 mins):Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 3Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 4Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2
... cut unnecessary biopsies, researchers say , WEDNESDAY, March 3 ... ways to treat and detect stubborn forms of prostate ... being presented this week at the annual Genitourinary Cancers ... of the prostate, kidney, bladder and testicles," Dr. Nicholas ...
... ... ... ... ...
... ... ... ... WASHINGTON , March 3 Michael A. Stephens , MPH, has joined the Association of ...
... commonly believed , WEDNESDAY, March 3 (HealthDay News) -- Early ... to a new study that may trigger a major change ... been believed that glaucoma -- the leading cause of blindness ... eye that damages the retina and optic nerve, so treatments ...
... ... ... ... ...
... MAYWOOD, Ill. -- A daily dose of vitamin D may ... winter, according to researchers at Loyola University Chicago Marcella Niehoff ... weather months when days are short and more time is ... problem despite the nutrient,s widely reported health benefits," said Sue ...
Cached Medicine News:Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 2Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 3Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 2Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 3Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 5Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 6Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 2Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 3Health News:Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows 2Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 2Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 3Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 4Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 5Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 6Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 7Health News:Vitamin D lifts mood during cold weather months 2
Hartman Mosquito forceps, straight, 3.5"....
Straight 20 mm serrated jaws. Ring handle with ratchet lock and dull finish. Overall length 3.9 inches...
Curved 21 mm serrated jaws. Ring handle with ratchet lock and dull finish. Most popular size or model. Overall length 4.7 inches...
Straight 22 mm serrated jaws. Ring handle with ratchet lock and dull finish. Overall length 4.9 inches...
Medicine Products: